BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 3, 2002
View Archived Issues
Abreva approved for OTC sale in Canada, Korea
Read More
Photofrin sNDA filed, orphan drug status granted, in high-grade dysplasia in Barrett's esophagus
Read More
Sankyo and Ube present antibacterial quinolizinones
Read More
New prenyltransferase inhibitors in early development at Merck
Read More
Fujisawa patents series for use in urinary incontinence
Read More
Novel calcilytic compounds and their use described in GSK patent
Read More
Aventis Pharma presents novel NHE3 inhibitors
Read More
VLA-4 antagonists with potential in asthma and inflammation
Read More
Antitumor xanthone compounds obtained from Streptomyces
Read More
Heat shock protein coinducer BRX-220 effective in rat model of acute pancreatitis
Read More
Effects of new SERM on bone, cholesterol and uterus compared to EE2 and levormeloxifene
Read More
Endogenous neuroprotective factor identified by Japanese group
Read More
Final analysis of phase III data for Zamyl in AML
Read More
Survival benefit for long-term atrasentan in HRPCa
Read More
Delay in PSA and clinical progression of prostate cancer achieved using Prostvac
Read More
KRX-211 has potential in septic shock
Read More
Neurontin receives FDA approval for postherpetic neuralgia
Read More
HIV immune responses induced by Remune plus CpG adjuvant in monkeys
Read More
Phase I study of aplidine as a three-hour infusion in solid tumor patients
Read More
Phase I/II enrollment completed for HuMax-IL-15 in rheumatoid arthritis
Read More
Endocyte licenses Galenica's GP-0100 for vitamin-based cancer treatments
Read More
Vion reprioritizes development program
Read More
Interim data announced from Neotrofin pilot study in Parkinson's disease
Read More
CPMP recommends approval of Visudyne in occult subfoveal CNV secondary to AMD
Read More